Previous close | 1.5500 |
Open | 0.0000 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.0000 - 0.0000 |
52-week range | |
Volume | |
Avg. volume | 955,937 |
Market cap | 5.42M |
Beta (5Y monthly) | 2.47 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor Forum held March 7th are now available for online viewing. This event was sponsored by Zacks Small-Cap Research. REGISTER NOW AT: https://bit.ly/3T80zZl The company presentations will be available 24/7 for 90
Genflow invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.comLONDON, March 05, 2024 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (LSE:GENF) (OTCQB:GENFF), an emerging leader in the field of longevity research developing therapeutics that can potentially halt or slow the ageing process, today announces that Dr. Eric Leire Chief Executive Officer, will present live at the virtual Life Science Investor Forum,
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum to be held March 7th. This event is sponsored by Zacks Small-Cap Research. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/430WqL8It is recomm